To allow all team members at St. Luke’s and those at organizations we’ve partnered with to focus on immediate needs due to COVID-19, the launch of the trial has been delayed. Understanding the anticipated increases in support needs for individuals with suicidal ideation, the trial will resume as soon as reasonably possible.
Suicide and mental health are top health concerns that have been identified in our communities. One person dies by suicide every 12 minutes in the United States making it one of the leading causes of death. Idaho has one of the highest rates of suicide in the nation and is 50% above the national average.
Therefore, St. Luke’s is using a research award from the Patient-Centered Outcomes Research Institute (PCORI) for a study of suicide prevention techniques in adults and adolescents. The study, known as the Suicide Prevention Among Recipients of Care (SPARC) trial, will compare two proven interventions already in practice at St. Luke’s. Those include structured safety planning with follow-up support from a suicide prevention hotline versus safety planning alone.
Study Goal: The goal is to use the data to determine the most-effective approach to preventing someone from taking their life and ensure that people receive the appropriate behavioral health treatment.
To learn more about SPARC trial details and subscribe to study updates, visit the PCORI website.
Potential participants for the study may be identified after they receive care at a St. Luke's facility. All potential participants will need to meet study requirements. We are not able to guarantee placement in the SPARC trial.
An important step in managing mental health is establishing consistent care with a provider. If you need to establish care, please call (208) 381-9000 to see which St. Luke's providers are accepting new patients.